United States · FDA National Drug Code directory
Telmisartan and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-209_ef7e32c5-7fa8-4179-927e-79d19a6f449e
- Product NDC
- 62332-209
- Form
- TABLET
- Composition / generic term
- Telmisartan and Hydrochlorothiazide
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160625
- Source listing expiry
- 20261231
Source-listed ingredients
- TELMISARTAN — 40 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 CARTON (62332-209-10) · 62332-209-10
- 30 TABLET in 1 BOTTLE (62332-209-30) · 62332-209-30
- 1000 TABLET in 1 BOTTLE (62332-209-91) · 62332-209-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →